The dynamic structure of α-synuclein multimers
- PMID: 23398399
- DOI: 10.1021/ja310518p
The dynamic structure of α-synuclein multimers
Abstract
α-Synuclein, a protein that forms ordered aggregates in the brains of patients with Parkinson's disease, is intrinsically disordered in the monomeric state. Several studies, however, suggest that it can form soluble multimers in vivo that have significant secondary structure content. A number of studies demonstrate that α-synuclein can form β-strand-rich oligomers that are neurotoxic, and recent observations argue for the existence of soluble helical tetrameric species in cellulo that do not form toxic aggregates. To gain further insight into the different types of multimeric states that this protein can adopt, we generated an ensemble for an α-synuclein construct that contains a 10-residue N-terminal extension, which forms multimers when isolated from Escherichia coli. Data from NMR chemical shifts and residual dipolar couplings were used to guide the construction of the ensemble. Our data suggest that the dominant state of this ensemble is a disordered monomer, complemented by a small fraction of helical trimers and tetramers. Interestingly, the ensemble also contains trimeric and tetrameric oligomers that are rich in β-strand content. These data help to reconcile seemingly contradictory observations that indicate the presence of a helical tetramer in cellulo on the one hand, and a disordered monomer on the other. Furthermore, our findings are consistent with the notion that the helical tetrameric state provides a mechanism for storing α-synuclein when the protein concentration is high, thereby preventing non-membrane-bound monomers from aggregating.
Similar articles
-
Bacterial in-cell NMR of human α-synuclein: a disordered monomer by nature?Biochem Soc Trans. 2012 Oct;40(5):950-4. doi: 10.1042/BST20120096. Biochem Soc Trans. 2012. PMID: 22988846 Review.
-
Distinct phases of free α-synuclein--a Monte Carlo study.Proteins. 2012 Aug;80(9):2169-77. doi: 10.1002/prot.24107. Epub 2012 Jun 12. Proteins. 2012. PMID: 22552968
-
Explaining the structural plasticity of α-synuclein.J Am Chem Soc. 2011 Dec 7;133(48):19536-46. doi: 10.1021/ja208657z. Epub 2011 Nov 14. J Am Chem Soc. 2011. PMID: 22029383 Free PMC article.
-
Macromolecular crowding in the Escherichia coli periplasm maintains alpha-synuclein disorder.J Mol Biol. 2006 Feb 3;355(5):893-7. doi: 10.1016/j.jmb.2005.11.033. Epub 2005 Dec 1. J Mol Biol. 2006. PMID: 16343531
-
Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?Mov Disord. 2013 Jan;28(1):31-40. doi: 10.1002/mds.25373. Mov Disord. 2013. PMID: 23390095 Review.
Cited by
-
From intrinsically disordered protein to context-dependent folding: The α-synuclein tetramer is teased out of hiding.Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9502-3. doi: 10.1073/pnas.1512077112. Epub 2015 Jul 23. Proc Natl Acad Sci U S A. 2015. PMID: 26204916 Free PMC article. No abstract available.
-
Protein Ensembles: How Does Nature Harness Thermodynamic Fluctuations for Life? The Diverse Functional Roles of Conformational Ensembles in the Cell.Chem Rev. 2016 Jun 8;116(11):6516-51. doi: 10.1021/acs.chemrev.5b00562. Epub 2016 Jan 25. Chem Rev. 2016. PMID: 26807783 Free PMC article. Review.
-
The Role of Glial Mitochondria in α-Synuclein Toxicity.Front Cell Dev Biol. 2020 Nov 11;8:548283. doi: 10.3389/fcell.2020.548283. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33262983 Free PMC article. Review.
-
Generation of G51D and 3D mice reveals decreased α-synuclein tetramer-monomer ratios promote Parkinson's disease phenotypes.NPJ Parkinsons Dis. 2024 Feb 29;10(1):47. doi: 10.1038/s41531-024-00662-w. NPJ Parkinsons Dis. 2024. PMID: 38424059 Free PMC article.
-
Rationally Designed Variants of α-Synuclein Illuminate Its in vivo Structural Properties in Health and Disease.Front Neurosci. 2018 Sep 25;12:623. doi: 10.3389/fnins.2018.00623. eCollection 2018. Front Neurosci. 2018. PMID: 30319334 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources